Mohamed Boutjdir PhD

AMCN President. Dr. Boutjdir is a Professor at the Department of Medicine at NYU School of Medicine and a Professor and Associate Chair of Medicine for R&D at the Departments of Medicine, Cell Biology, and Pharmacology & Physiology at SUNY Downstate Medical Center, New York. He is also, the Director of the Cardiovascular Research Program at the VA New York Harbor Healthcare System, New York. Dr. Boutjdir’s interest is in cardiovascular research both in health and diseased states. Specifically, Dr. Boutjdir’s research includes the mechanisms of autoimmune-associated congenital heart block, atrial fibrillation, and long QT syndrome.

Dr. Boutjdir serves on several review boards for cardiovascular study sections for many granting institutions such as the National Institutes of Health, the American Heart Association both local and National Centers, the Veterans Administration, the March of Dimes, and the French “Agence Nationale de la Recherche”. Dr. Boutjdir also serves as a reviewer for many National and European high-impact journals and is an active member of several journal editorial boards. He has been invited throughout the world to lecture and present seminars in the area of cardiovascular research. To date, he has published over 85 peer-reviewed manuscripts and book chapters.

Dr. Boutjdir, in addition to being an academic, has extensive leadership, management, and administrative experiences in a range of organizational contexts. In most of these, he had the responsibility for strategic as well as operational planning, working with Senior Executive Management teams such as the Deans of Medical Schools (NYU and SUNY Downstate @ New York), Hospital CEOs, and Clinical Service Chiefs. He has led and managed a group of more than 300 investigators/researchers, clinical, translational, and basic scientists, and managed a research budget of more than $15 Million. Dr. Boutjdir worked on providing support and promoting research and scholarly activity by building new directions in research, establishing centers of excellence, ensuring responsible research practices, and communicating the value of research within and beyond the institution. He provided expertise and support to faculty and staff in the commercialization of intellectual property and help bring these new ideas to the marketplace.